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Abstract
Objectives The Eastern Mediterranean Region faces sev-
eral health challenges at a difficult time with wars, unrest,
and economic change.
Methods We used the Global Burden of Disease 2015
study to present the burden of diseases, injuries, and risk
factors in the Eastern Mediterranean Region from 1990 to
2015.
Results Ischemic heart disease was the leading cause of
death in the region in 2015, followed by cerebrovascular
disease. Changes in total deaths ranged from a reduction of
25% for diarrheal diseases to an increase of about 42% for
diabetes and tracheal, bronchus, and lung cancer. Collec-
tive violence and legal intervention increased by 850%
during the time period. Diet was the leading risk factor for
disability-adjusted life years (DALYs) for men compared
to maternal malnutrition for females. Childhood undernu-
trition was the leading risk factor for DALYs in 1990 and
2005, but the second in 2015 after high blood pressure.
Conclusions Our study shows that the region is facing
several health challenges and calls for global efforts to
stabilise the region and to address the current and future
burden of disease.
Keywords Burden of disease  Eastern Mediterranean
Region  Injuries  Risk factors  Disability-adjusted life
years
Introduction
The Eastern Mediterranean Region (EMR) is home to more
than 500 million people, representing a diverse group of 22
countries: Afghanistan, Arab Republic of Egypt, Bahrain,
Djibouti, Iraq, Islamic Republic of Iran, Jordan, Kingdom
of Saudi Arabia (KSA), Kuwait, Lebanon, Libya, Morocco,
Oman, Pakistan, Palestine, Qatar, Republic of Yemen,
Somalia, Sudan, Syrian Arab Republic (Syria), Tunisia,
and the United Arab Emirates (UAE). These countries have
different gross domestic products, socio-demographic
profiles, health indicators, and health system capacities and
coverage (WHO EMRO 2017; Mandil et al. 2013). About
12.2% of the population comprises children under 5 years
of age, and 20% are women of childbearing age (WHO
EMRO 2013).
The region also has wide variation in per capita gross
national product (GNP), ranging from a high of $134,420
in Qatar to a low of $2000 in Afghanistan (The World
Bank GNI per capita 2017). While the Gulf States are some
of the richest countries globally, poverty rates remain high
in many other countries of the EMR. The proportion of the
population living below the national poverty line, accord-
ing to World Bank data, is more than 20% in seven EMR
countries: Afghanistan (36%), Egypt (22%), Iraq (23%),
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Pakistan (22%), Palestine (22%), Sudan (47%), and Yemen
(35%). In five of these countries, approximately one-third
of the population is also food-insecure: Afghanistan (34%),
Iraq (30%), Pakistan (30%), Sudan (33%), and Yemen
(36%) (The World Bank Databank 2017).
This region faces several health challenges at a difficult
time with wars, unrest, and economic changes (Mokdad
et al. 2014, 2016). These events will put a strain on limited
resources and impact the health gains achieved so far. In
addition, the EMR has a large, young population, and
current events will shape the well-being of future
generations.
In this issue of the Journal, we report the burden of
several diseases and risk factors in separate manuscripts:
intentional injuries, lower respiratory infections, maternal
mortality, mental health, obesity, vision loss, road traffic
injuries, adolescent health, cancer, cardiovascular disease,
child mortality, diabetes and chronic kidney disease, diar-
rhoea, and HIV (GBD 2015 EMR Diabetes and Chronic
Kidney Disease Collaborators 2017e; GBD 2015 EMR
Child Mortality Collaborators 2017d; GBD 2015 EMR
HIV Collaborators 2017g; GBD 2015 EMR Diarrhea Dis-
ease Collaborators 2017f; GBD 2015 EMR Cancer Col-
laborators 2017c; GBD 2015 EMR Intentional Injuries
Collaborators 2017h; GBD 2015 EMR Cardiovascular
Disease Collaborators 2017b; GBD 2015 EMR Adolescent
Health Collaborators 2017a; GBD 2015 EMR Lower
Respiratory Infections Collaborators 2017i; GBD 2015
EMR Vision Loss Collaborators 2017n; GBD 2015 EMR
Maternal Mortality Collaborators 2017j; GBD 2015 EMR
Transportation Injuries Collaborators 2017m; GBD 2015
EMR Obesity Collaborators 2017l; GBD 2015 EMR
Mental Disorders Collaborators 2017k). These topics were
selected based on the burden of disease in the region as
well as the interest of the collaborators and the scientific
community. This manuscript provides the overall burden of
diseases, injuries, and risk factors in the Eastern Mediter-
ranean Region from 1990 to 2015 and provides an update
of our previous publications (Mokdad et al. 2014, 2016;
Khalil et al. 2016; Moradi-Lakeh et al. 2017a; Moradi-
Lakeh et al. 2017b; Charara et al. 2017).
Methods
Overview
The Global Burden of Disease (GBD) 2015 methodology
has been published elsewhere (Forouzanfar et al. 2016;
Kassebaum et al. 2016a, b; Vos et al. 2016; Wang et al.
2016a, b). GBD 2015 uses a comprehensive approach to
report causes of death with garbage code redistribution; a
systematic and simultaneous estimation of disease
incidence, prevalence, exposure to risks, and injuries; and
statistical models to pool data, adjust for bias, and incor-
porate covariates. It uses several metrics to report results
for health loss related to specific diseases, injuries, and risk
factors: deaths and death rates, years of life lost due to
premature mortality (YLLs), prevalence and prevalence
rates for sequelae, years lived with disability (YLDs), and
disability-adjusted life years (DALYs). It provides a com-
prehensive assessment of all-cause mortality and causes of
death estimates due to 249 causes in 195 countries and
territories from 1990 to 2015.
GBD estimates incidence and prevalence by age, sex,
cause, year, and geography using a wide range of updated
and standardised analytical procedures. GBD uses DisMod-
MR, a Bayesian meta-regression tool first developed for
GBD 2010 and GBD 2013 to determine prevalence and
incidence by cause and sequelae.
GBD 2015 used the comparative risk assessment (CRA)
framework developed for previous iterations of the GBD
study to estimate attributable deaths, DALYs, and trends in
exposure by age group, sex, year, and geography for 79
behavioural, environmental and occupational, and meta-
bolic risks or clusters of risks over the period 1990–2015.
Risk-outcome pairs were included in the GBD 2015 study
if they met World Cancer Research Fund criteria for con-
vincing or probable evidence. Relative risk estimates were
extracted from published and unpublished randomised
controlled trials, cohorts, and pooled cohorts. Risk expo-
sures were estimated based on published studies, household
surveys, census data, satellite data, and other sources. Two
modelling approaches—a Bayesian meta-regression model
and a spatiotemporal Gaussian process regression model—
developed for the GBD study were used to pool data from
different sources, adjust for bias in the data, and incorpo-
rate potential covariates. GBD uses the counterfactual
scenario of theoretical minimum risk exposure level
(TMREL) to attribute burden. TMREL is the level for a
given risk exposure that could minimise risk at the popu-
lation level. A summary exposure value (SEV) was
developed for GBD 2015 as the relative risk-weighted
prevalence of exposure. SEV ranges from zero when no
excess risk exists in a population to one when the popu-
lation is at the highest risk.
Socio-demographic Index and decomposition
of variance
GBD 2015 created a Socio-demographic Index based on
lag-dependent income per capita, average educational
attainment for ages 15 or older, and the total fertility rate.
To analyse the drivers of change, GBD 2015 decomposed
trends in diseases and attributable burden into contributions
from population growth, change in population structure by
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age and sex, risk exposure, and risk-deleted cause-specific
DALY rates.
GBD 2015 has four levels of causes that are mutually
exclusive and exhaustive. Level 1 has three causes: com-
municable, maternal, neonatal, and nutritional disorders;
non-communicable diseases; and injuries. Level 2 has 21
causes, while Levels 3 and 4 consist of disaggregated
causes. GBD 2015 documented each step of the estimation
processes, as well as data sources, in accordance with
Guidelines for Accurate and Transparent Health Estimates
Reporting (GATHER).
Results
Our results showed a major shift in burden of disease in the
region and a wide variation by countries. Ischaemic heart
disease (IHD) was the leading cause of death in the region
in 2015, followed by cerebrovascular disease (Fig. 1).
Among the leading 30 causes of deaths, there were varia-
tions in the drivers of changes in mortality from population
growth, ageing, and changes to age-standardised rates of
cause-specific mortality from 2005 to 2015. Changes in
total deaths ranged from a reduction of 25% for diarrheal
diseases to an increase of about 42% for diabetes and tra-
cheal, bronchus, and lung cancer. Population growth
accounted for increases across all causes, while population
ageing led to increases in 18 causes. Declines
attributable to changes in age-specific and cause-specific
mortality rates varied markedly. Collective violence and
legal intervention increased by 850% during the time
period.
Figure 2 shows the leading causes of disease burden
over time in the EMR. Ischemic heart disease was the
leading cause of DALYs followed by neonatal preterm
birth complications, neonatal encephalopathy, lower res-
piratory infections, and war and legal intervention.
Figure 3 shows the changes in the leading causes of
DALYs from 2005 to 2015 by age. Violence and war
increased from an early age to 55 years old. Diabetes
increased among ages 40 and older. There were declines in
some infectious diseases among children under 5. IHD
remained the leading cause of DALYs for ages 40 and
older.
Figure 4 shows the expected relationship between age-
standardised and crude YLL and YLD rates for the region
from 1990 to 2015 for Level 2 causes. Expected age-s-
tandardised YLL rates for infectious diseases declined with
increased SDI. Cardiovascular disease (CVD) age-stan-
dardised YLL rates also declined with increased SDI. At
the same time, age-standardised YLD rates for the top
causes did not change much with SDI. At the higher SDI
levels, YLD rates were the same as or higher than YLL
rates. The spikes that appear at the left side of the fig-
ure show the impact of conflict and war. Increases are seen
in YLLs from causes like war and injuries, as expected, but
also from other types of causes, underscoring the effects
these conflicts have on health systems when they occur.
Figure 5 shows the EMR DALYs attributable to Level 2
risk factors for men and women in 2015. Diet is the leading
risk factor for men, followed by high systolic blood pres-
sure. Most of the DALYs burden for men is due to car-
diovascular diseases and diabetes. Child and maternal
malnutrition was the leading risk factor for DALYs for
females, followed by diet. Child and maternal malnutrition
impacted diarrhoea, lower respiratory infections, and
nutritional deficiencies, while diet impacted CVD and
diabetes.
Figure 6 shows the EMR DALYs attributable to Level 3
risk factors and their changes from 1990 to 2005 and 2005
to 2015. Childhood undernutrition was the leading risk
factor for DALYs in 1990 and 2005, but the second-leading
in 2015 after high blood pressure. The percent change in
the age-standardised DALY rate from 1990 to 2005 was a
decline of 48%, compared to a decline of 43.4% from 2005
to 2015. Both obesity and high fasting plasma glucose
increased from 1990 to 2005 and from 2005 to 2015, but
the rate of increase was slower from 2005 to 2015.
e-Figure 1 shows the decomposition of changes for all-
cause DALYs to Level 3 risk factors from 1990 to 2015 for
the region. Overall changes in in all causes of DALYs
ranged from a decline of 75% to an increase of a little over
200%. Population growth contributed to the increase in
DALYs for all risk factors, while population ageing con-
tributed to an increase for 33 causes. Drug use had the
highest increase in risk exposure, followed by high body
mass index and high fasting plasma glucose. Changes in
the risk-deleted DALYs rate resulted in a decline in all but
six causes.
Discussion
Our study shows that the region is facing several health
challenges in addition to the impact of the ongoing wars
and unrest. The region is dealing with an epidemiological
shift in burden from infectious to chronic diseases. How-
ever, the recent events may lead to a resurgence of some
communicable diseases that were declining before these
events. Moreover, countries will have a strain on their
efforts to control and prevent non-communicable diseases.
Our findings call for global efforts to stabilise the region
and to address the current and future burden of disease.
In addition, but also linked to other effects of unrest,
several risk factors affecting health are present. Efforts to
reduce and prevent these risk factors in the region should
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be a health priority. For example, poor diet is the leading
cause of DALYs in the region. Many countries in the
region are suffering from malnutrition and at the same time
from poor diet that is leading to disease. Tobacco smoking
and systolic blood pressure are among the top causes of
DALYs. Some countries in the region need to enforce
regulations on tobacco to control and prevent smoking
initiation. Blood pressure medication is now cheap and
affordable for many in the EMR, but this may not be true
for some low-income countries in the region. However,
mechanisms for early detection and proper management of
high blood pressure should be adopted to reduce this bur-
den. Viral hepatitis accounts for a large burden in the
region, especially in Somalia, Pakistan, Djibouti, Afgha-
nistan, and Egypt (Institute for Health Metrics and Evalu-
ation 2016). The burden of hepatitis requires efforts to
prevent the spread of the disease through minimising risk
factors and providing proper immunizations. Moreover,
screening and treatment for hepatitis C should be
encouraged.
The EMR has a large burden from ambient air pollution.
Ambient air pollution is associated with increased mortal-
ity and morbidity (WHO 2005). Our study showed that
ambient particulate matters are the 5th leading DALYs
risk. We have previously reported on the global rise in the
burden of air pollution (Cohen et al. 2017).
Several countries in the region face a major environ-
mental challenge due to lack of water, rising temperatures,
and sand storms. Our findings call for renewed efforts to
address the burden of ambient air pollution. Indeed, unlike
other risk factors or challenges faced by the region, envi-
ronmental health requires strong governmental commit-
ments to implement the global environmental standards
and utilise the currently available technologies to reduce
the burden.
The wars in the region, especially in Yemen, Iraq, and
Syria, are taking a large toll on the health of the population.
The immediate impact of the wars has been very high, with
increased mortality due to violence. Moreover, these events
will lead to increased health burden in the future as the next
generation in many countries in the region is being raised
under the harsh conditions of malnutrition and lack of
preventive health services.
The wars and unrest have led to major migration and a
large refugee population inside and outside the region. For
many host countries, the existing health systems and
infrastructure do not support such a large additional pop-
ulation. In Lebanon, for example, public schools are
Fig. 1 Eastern Mediterranean Region decomposition of changes in
leading 30 causes of death due to population growth, population
ageing, and changes in age-specific mortality rates, 2005–2015.
Collective violence and legal intervention, which increased by 847%,
was truncated for display purposes (Global Burden of Disease 2015
study, Eastern Mediterranean Region, 1990–2015)
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providing education to Lebanese and Syrian children, but
the public school infrastructure is not capable of dealing
with such a large number of students. This has resulted in a
double shift in schools and put a large strain on the system.
The same applies to other services besides health, and in
other countries.
Countries in the region need to continue to strive to
achieve universal health coverage, strong screening and
prevention programs, and effective health delivery sys-
tems. The countries in the region can also learn from the
systems put in place for the training and accreditation of
health professionals, priority-setting, and the implementa-
tion of evidence-based health care undertaken by some
other developed countries. Investment in health systems
can create jobs and improve economic growth, in addition
to the direct benefits on health outcomes. It is also
important to look at the wider determinants of health—
such as poverty, housing, education, and employment; and
to empower women to have a dramatic effect on health
outcomes.
Despite the market failures, the private sector can still
play an important role in regional health systems. Provid-
ing an amiable environment to foster competition between
public and private providers will ensure better quality and
efficiency of services delivered. Better engagement of the
private providers can reduce the burden of financing on the
public sector. In this respect, movement from input-based
payment toward a performance-based payment system is
urgently needed. Furthermore, considering the variety of
health challenges facing the region, it is vital for the
countries to adopt concepts of health in all policies. This
can be achieved by developing a national body that focuses
on setting up collaborative efforts among all sectors to
incorporate health issues into all policy areas aiming to
promote, protect, preserve, and restore population health.
A critical component to improve current and future
health in the EMR is the ability to effectively and effi-
ciently diagnose the challenges to health and well-being
faced by the region. The Global Burden of Disease offers
accurate and comprehensive information on the global
burden of diseases, injuries, and risk factors, and develops
Fig. 2 Leading 30 level 3 Eastern Mediterranean Region causes of
disability-adjusted life-years (DALYs) for both sexes combined,
1990, 2005 and 2015. Causes are connected by arrows between time
periods. Communicable, maternal, neonatal and nutritional causes are
shown in red, non-communicable causes in blue and injuries in green.
For the time period 1990–2005 and for 2005–2015, three measures of
change are shown: percent change in the number of DALYs, percent
change in the all-age DALY rate and percent change in the age-
standardised DALY rate (Global Burden of Disease 2015 study,
Eastern Mediterranean Region, 1990–2015)
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new analytic methods and data visualisation tools to sup-
port the understanding of this information and to empower
policymakers and health leaders to act. However, the
region still has a long way to go in terms of having ade-
quate and timely data to better inform decision-makers of
the burden. Therefore, there is an urgent need to improve
vital statistics, data sources, and surveillance systems in the
region to better serve their purpose.
The region is in dire need of a comprehensive plan to
build on existing expertise and projects to address the
health challenges that exist at the nexus of human health,
environmental resilience, and social and economic equity.
The region does not have proper health translation and
implementation efforts to address its growing health chal-
lenges. Unfortunately, many countries have focused on
curative rather than preventive systems. Indeed, this will
limit the pace of progress needed to address many of the
emerging challenges such as non-communicable diseases
and the emergence of infectious diseases in countries with
wars and unrest. This lack of progress is evidenced by wide
health disparities between and within countries and exists
despite the identified organisations and forums that offer
recommendations for intervention, such as the World
Health Organization and others.
This comprehensive plan needs to review and compile
information on prior health interventions for each targeted
topical area of burden from peer-reviewed and grey liter-
ature and include both successful and negative outcomes
(as much can be learned from failures as from successes),
as well as potential unintended consequences of interven-
tions. The plan should include a synthesis of the available
quantitative and qualitative evidence on interventions and
innovations to develop a summary of why specific work
around a risk or disease succeeds or fails. This analysis will
develop a deeper understanding of the necessary ingredi-
ents for success (i.e., to identify underlying social, eco-
nomic, legal, and public policy features). This will allow
health actors to design and conduct innovative research on
intervention effectiveness, implementation, scale-up, dis-
semination, and economic return in partnership with
community, governments, foundations, and other collabo-
rators. This work should draw on resources including, but
not limited to, the United Nations’ Sustainable Develop-
ment Goals, the Disease Control Priorities publications,
and the World Health Organization’s ‘‘Best Buys’’.
Health education and training are crucial to improve the
burden of disease in the EMR. There is a dire need for
opportunities and funding to offer training for public offi-
cials (e.g., health ministers, policymakers, and local health
officers) and program leaders, provided both on-site and on
a regional scale at in-country sites in collaboration with
other countries. These trainings should provide participants
Fig. 3 Leading ten Level 3 causes of Eastern Mediterranean Region
age-specific disability-adjusted life-years (DALYs) in 2015. Each
cause is coloured by the percentage change in age-specific DALY rate
from 2005 to 2015. NN Preterm = neonatal preterm birth complica-
tions. NN Sepsis = neonatal sepsis and other neonatal infections.
LRI = lower respiratory infections. Iron = iron-deficiency anaemia.
HIV = HIV/AIDS. Back and neck = low back and neck pain.
IHD = ischaemic heart disease. NN Enceph = neonatal
encephalopathy due to birth asphyxia and trauma. Diarrhoea = diar-
rhoeal diseases. Skin = skin and subcutaneous diseases. Depres-
sion = depressive disorders. Stroke = cerebrovascular disease.
Congenital = congenital anomalies. Diabetes = diabetes mellitus.
COPD = chronic obstructive pulmonary disease. Alzheimer’-
s = Alzheimer’s disease and other dementias. PEM = protein-energy
malnutrition. Conduct = conduct disorder. Sense = sense organ
diseases. Other NN = other neonatal disorders. Intest inf = intestinal
infectious diseases. Violence = interpersonal violence. NN Hae-
mol = haemolytic disease and other neonatal jaundice. Anxi-
ety = anxiety disorders. TB = tuberculosis. Lung C = lung,
bronchial, and tracheal cancers. STD = sexually transmitted diseases
excluding HIV. Haemog = haemoglobinopathies and haemolytic
anaemias. CKD = chronic kidney disease. Other MSK = other
musculoskeletal disorders. Drugs = drug use disorders. HTN
HD = hypertensive heart disease. Whooping = whooping cough.
Other UI = other unintentional injuries. War = collective violence
and legal intervention. Cirrhosis Hep C = Cirrhosis and other chronic
liver diseases due to hepatitis C. Other Cardio = Other cardiovascu-
lar and circulatory diseases. GBD = Global Burden of Disease
(Global Burden of Disease 2015 study, Eastern Mediterranean
Countries, 2005–2015)
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with actual experience implementing the interventions that
have been developed. Finally, there is a need to scale up
the public health workforce across the region, to ensure
that the right policies are developed, implemented, and
enforced.
Health advocacy and effective program and policy dis-
semination must be at the forefront of all health activities.
The region needs a catalyst for change at both country and
regional levels by providing a platform on which local and
global strategies and successes are collaboratively shared
among local communities and countries. This, in turn, will
encourage adoption, successful implementation, and ulti-
mately, sustainability of population health.
The future of health in the region is grim unless the wars
and unrest stop. Regional health professionals are dealing
with overwhelming challenges and can barely meet basic
health needs. The best intervention for a better future is an
international plan to stabilise the region. All countries have
an equally important role to play in bringing an end to the
unrest and starting to rebuild.
Our study has some limitations. The availability and
quality of data for some countries in the region pose sub-
stantial challenges for cause of death analysis. Many
Fig. 4 a Expected relationship
between age-standardised years
of life lost (YLL) and years
lived with disability (YLD)
rates per 100,000 and
Sociodemographic index (SDI)
and b all-age YLL and YLD
rates (per 100,000) and SDI for
21 GBD Level 2 causes. These
stacked curves represent the
average relationship between
SDI and each cause observed
across the 22 Eastern
Mediterranean Region countries
in 2015. In each figure, the y-
axis goes from lowest SDI to
highest SDI. The left side shows
rates for YLLs and the right side
shows rates for YLDs; higher
rates are further from the
midline. The difference between
(a) and (b) is the effect of shifts
in population age structure
expected with SDI.
GBD = Global Burden of
Disease (Global Burden of
Disease 2015 study, Eastern
Mediterranean Countries,
1990–2015)
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countries in the region do not have strong vital registration
systems. Our GBD methodology makes extensive efforts to
reduce the effects of variable data quality, and we have
used standardised methods for each cause that are the same
for all countries. We also provide uncertainty intervals for
each of our estimates that take into account the data issues,
and we provide all our data sources and show what is
available for every country on our website (Institute for
Health Metrics and Evaluation 2017). Our web visualisa-
tions allow comparison of raw data to final estimates and
show the impact of our models and methods of dealing
with data quality or lack of it. Finally, our study provides
the national burden and hence masks large disparities
within a country.
Conclusion
Our study shows a tremendous impact of war and violence
on the health of the region. The results show that in recent
years, many of the health gains for some countries have
slowed and several health conditions that were under
control are re-emerging. These findings clearly indicate
Fig. 5 Eastern Mediterranean
Region disability-adjusted life-
years (DALYs) attributable to
Level 2 risk factors for (a) men
and (b) women in 2015 (Global
Burden of Disease 2015 study,
Eastern Mediterranean
Countries, 1990–2015)
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that the future health of the region is in danger. Immediate
efforts to stabilise the region and improve the health of the
population are urgently needed.
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